Non-Hodgkin Lymphoma — An Interview with Dr Jennifer Crombie on the Use of Bispecific Antibodies
Research To Practice | Oncology Videos · Dr. Neil Love
May 20, 202549m 55s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring an interview with Dr Jennifer Crombie, including the following topics:
- Overview of similarities and differences among CD20 x CD3 targeted bispecific antibodies for the treatment of lymphomas (0:00)
- Optimal integration of CD20 x CD3 bispecific antibodies into treatment algorithms for lymphomas (9:40)
- Case: A man in his late 60s with relapsed follicular lymphoma (FL) who received mosunetuzumab (23:52)
- Case: A man in his late 80s with transformed, double-hit diffuse large B-cell lymphoma (DLBCL) who received epcoritamab (28:46)
- Case: A woman in her early 70s with recurrent FL who received odronextamab on the ELM-1 trial (34:06)
- Case: A man in his early 80s with multiregimen-relapsed DLBCL who receives glofitamab (43:19)